IPO Enablement CBT Advisors has a strong track record drafting business sections for NASDAQ IPOs with clients that have gone public and raised substantial capital, signaling opportunities to offer enhanced IPO storytelling and capital markets advisory services to biotech firms preparing for or evaluating public offerings.

Biotech Focus Specializing in private biotechnology, life sciences, and medical devices, CBT Advisors sits at the intersection of high-growth biotech companies and investor storytelling, presenting opportunities to cross-sell expansion services such as strategy storytelling, regulatory narrative development, and investor targeting.

Growth Ready Prospects With a client history including notable IPOs like Zentalis, Repare, and Legend Biotech, there is a pipeline of growth-stage firms likely preparing for or pursuing public markets, creating sales motion around pre-IPO readiness, roadshows, and equity story optimization.

Lean Engagement Operating with a small team (2-10 employees) yet a proven impact on large capital raises, CBT Advisors could benefit from scalable services such as automated content templates, training, and scalable advisory bundles to extend capacity without compromising quality.

Digital & Ops Leverage Current tech stack and digital presence (Google Workspace, hosting, Apache, search tooling) offer a pathway to introduce SaaS-enabled collaboration, client portal enhancements, and data-driven project management to improve efficiency for private firms seeking story and strategy services.